Fisher’s Exact Test Chi- square tests QQ plots Type I Error Dose Comparison Secondary endpoint Subgroup Analysis by Type 2 Diabetes Status Retrospective cohort design Lack of treatment controls 175 patients Primary endpoint Nominal categorical variables Follow- up period Paired student’s T-test Interquartile range Reject the null hypothesis Responder: weight loss Anova Secondary Endpoints Histograms Boxplots Medians Two-Sample Independent T-Test Fail to reject the null hypothesis P<0.05 Weight before semaglutide to weight at 3 months Predictor: Semaglutide, BMI, Diabetes Degrees of Freedom Continuous numerical variables Normally distributed Adverse effects Type II error Ordinal Categorical Variables Weight before semaglutide to weight at 6 months Discrete numerical variables Fisher’s Exact Test Chi- square tests QQ plots Type I Error Dose Comparison Secondary endpoint Subgroup Analysis by Type 2 Diabetes Status Retrospective cohort design Lack of treatment controls 175 patients Primary endpoint Nominal categorical variables Follow- up period Paired student’s T-test Interquartile range Reject the null hypothesis Responder: weight loss Anova Secondary Endpoints Histograms Boxplots Medians Two-Sample Independent T-Test Fail to reject the null hypothesis P<0.05 Weight before semaglutide to weight at 3 months Predictor: Semaglutide, BMI, Diabetes Degrees of Freedom Continuous numerical variables Normally distributed Adverse effects Type II error Ordinal Categorical Variables Weight before semaglutide to weight at 6 months Discrete numerical variables
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Fisher’s Exact Test
Chi-square tests
QQ plots
Type I Error
Dose Comparison
Secondary endpoint
Subgroup Analysis by Type 2 Diabetes Status
Retrospective cohort design
Lack of treatment controls
175 patients
Primary endpoint
Nominal categorical variables
Follow-up period
Paired student’s T-test
Interquartile range
Reject the null hypothesis
Responder: weight loss
Anova
Secondary Endpoints
Histograms
Boxplots
Medians
Two-Sample Independent T-Test
Fail to reject the null hypothesis
P<0.05
Weight before semaglutide to weight at 3 months
Predictor: Semaglutide, BMI, Diabetes
Degrees of Freedom
Continuous numerical variables
Normally distributed
Adverse effects
Type II error
Ordinal Categorical Variables
Weight before semaglutide to weight at 6 months
Discrete numerical variables